Table of Contents
1.1 List of Tables
Table 1: Healthcare Expenditure in Japan, 2000 - 2005
15
Table 2: Number of Healthcare Institutions in Japan, 1995 - 2004 17
Table 3: Number of Hospital Beds in Japan, 1995 - 2004 18
Table 4: Number
of Medical Personnel in Japan, 1995 - 2004 18
Table 5: Number of Doctors
by Specialty in Japan, 2003-2007 19
Table 6: Number of Medical Care
Institutions and Beds in Japan, 2000 - 2004 20
Table 7: Registration
Processing Time for Medical Devices in Japan, 2007 26
Table 8: Product
Registration Fee for Medical Devices in Japan, 2007 26
Table 9:
Diabetes Care Devices, Japan, Overall Revenue ($ mn), Historic, 2000-2008
32
Table 10: Diabetes Care Devices, Japan, Overall Revenue ($ mn),
Forecast, 2008-2015 33
Table 11: Diabetes Care Devices, Japan,
Category Volume (Units) by Segment, Historic, 2000-2008 34
Table 12:
Diabetes Care Devices, Japan, Category Volume (Units) by Segment, Forecast,
2008-2015 35
Table 13: Diabetes Care Devices, Japan, Cross-Category
Analysis, 2000-2015 36
Table 14: Diabetes Care Devices, Japan,
Company Share by Revenue ($ mn), 2006-2007 38
Table 15: Glucose
Monitoring, Japan, Revenue ($ mn) by Segment, Historic, 2000-2008 40
Table
16: Glucose Monitoring, Japan, Revenue ($ mn) by Segment, Forecast,
2008-2015 41
Table 17: Glucose Monitoring, Japan, Volume (Units) by
Segment, Historic, 2000-2008 42
Table 18: Glucose Monitoring, Japan,
Volume (Units) by Segment, Forecast, 2008-2015 43
Table 19: Glucose
Monitoring, Japan, Cross Segment Analysis, 2000-2015 44
Table 20:
Glucose Monitoring, Japan, Average Price ($), Historic, 2000-2008 45
Table
21: Glucose Monitoring, Japan, Average Price ($), Forecast, 2008-2015
45
Table 22: Glucose Monitoring, Japan, Distribution Share by Revenue
($mn), 2007-2008 46
Table 23: Glucose Monitoring, Japan, Company
Share by Revenue ($ mn), 2006-2007 47
Table 24: Insulin Delivery,
Japan, Revenue ($ mn) by Segment, Historic, 2000-2008 48
Table 25:
Insulin Delivery, Japan, Revenue ($ mn) by Segment, Forecast, 2008-2015 49
Table 26: Insulin Delivery, Japan, Volume (Units) by Segment, Historic,
2000-2008 50
Table 27: Insulin Delivery, Japan, Volume (Units) by
Segment, Forecast, 2008-2015 51
Table 28: Insulin Delivery, Japan,
Cross Segment Analysis, 2000-2015 52
Table 29: Insulin Delivery,
Japan, Average Price ($), Historic, 2000-2008 53
Table 30: Insulin
Delivery, Japan, Average Price ($), Forecast, 2008-2015 54
Table 31:
Insulin Delivery, Japan, Distribution Share by Revenue ($mn), 2007-2008 55
Table 32: Insulin Delivery, Japan, Company Share by Revenue ($ mn),
2006-2007 56
Table 33: ARKRAY, Inc. Pipeline Products by Equipment
Type 57
Table 34: ARKRAY, Inc. Pipeline Products by Development Stage
57
Table 35: ARKRAY, Inc. Pipeline Products by Clinical Trials 58
Table 36: ARKRAY, Inc. Pipeline Products by News Summary 58
Table 37:
F. Hoffmann-La Roche Ltd Pipeline Products by Equipment Type 66
Table
38: F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage
66
Table 39: F. Hoffmann-La Roche Ltd Pipeline Products by Therapy
Area 66
Table 40: Bayer HealthCare AG Pipeline Products by Equipment
Type 70
Table 41: Bayer HealthCare AG Pipeline Products by
Development Stage 71
Table 42: Bayer HealthCare AG Pipeline Products
by Therapy Area 71
Table 43: Bayer HealthCare AG Pipeline Products by
News Summary 71
Table 44: Abbott Laboratories Pipeline Products by
Equipment Type 76
Table 45: Abbott Laboratories Pipeline Products by
Development Stage 76
Table 46: Abbott Laboratories Pipeline Products
by Therapy Area 76
Table 47: Abbott Laboratories Pipeline Products
by Clinical Trials 77
Table 48: Abbott Laboratories Pipeline
Products by News Summary 77
Table 49: LifeScan, Inc. Pipeline
Products by Equipment Type 78
Table 50: LifeScan, Inc. Pipeline
Products by Development Stage 78
Table 51: LifeScan, Inc. Pipeline
Products by Therapy Area 78
Table 52: LifeScan, Inc. Pipeline
Products by Clinical Trials 79
Table 53: LifeScan, Inc. Pipeline
Products by News Summary 79
Table 54: Medtronic, Inc. Pipeline
Products by Equipment Type 83
Table 55: Medtronic, Inc. Pipeline
Products By Development Stage 83
Table 56: Medtronic, Inc. Pipeline
Products By Therapy Area 84
Table 57: Medtronic, Inc. Pipeline
Products By Clinical Trials 84
Table 58: Novo Nordisk A/S Pipeline
Products by Equipment Type 85
Table 59: Novo Nordisk A/S Pipeline
Products By Development Stage 85
Table 60: Novo Nordisk A/S Pipeline
Products By Therapy Area 86
Table 61: Novo Nordisk A/S Pipeline
Products By Clinical Trials 86
Table 62: USD to Local Currency, Average
Exchange Rate 2008 93
1.1 List of Tables
Table 1: Healthcare
Expenditure in Japan, 2000 - 2005 15
Table 2: Number of Healthcare
Institutions in Japan, 1995 - 2004 17
Table 3: Number of Hospital Beds in
Japan, 1995 - 2004 18
Table 4: Number of Medical Personnel in Japan, 1995
- 2004 18
Table 5: Number of Doctors by Specialty in Japan, 2003-2007
19
Table 6: Number of Medical Care Institutions and Beds in Japan, 2000 -
2004 20
Table 7: Registration Processing Time for Medical Devices in
Japan, 2007 26
Table 8: Product Registration Fee for Medical Devices in
Japan, 2007 26
Table 9: Diabetes Care Devices, Japan, Overall Revenue
($ mn), Historic, 2000-2008 32
Table 10: Diabetes Care Devices,
Japan, Overall Revenue ($ mn), Forecast, 2008-2015 33
Table 11:
Diabetes Care Devices, Japan, Category Volume (Units) by Segment, Historic,
2000-2008 34
Table 12: Diabetes Care Devices, Japan, Category Volume
(Units) by Segment, Forecast, 2008-2015 35
Table 13: Diabetes Care
Devices, Japan, Cross-Category Analysis, 2000-2015 36
Table 14:
Diabetes Care Devices, Japan, Company Share by Revenue ($ mn), 2006-2007
38
Table 15: Glucose Monitoring, Japan, Revenue ($ mn) by Segment,
Historic, 2000-2008 40
Table 16: Glucose Monitoring, Japan, Revenue
($ mn) by Segment, Forecast, 2008-2015 41
Table 17: Glucose
Monitoring, Japan, Volume (Units) by Segment, Historic, 2000-2008 42
Table
18: Glucose Monitoring, Japan, Volume (Units) by Segment, Forecast,
2008-2015 43
Table 19: Glucose Monitoring, Japan, Cross Segment
Analysis, 2000-2015 44
Table 20: Glucose Monitoring, Japan, Average
Price ($), Historic, 2000-2008 45
Table 21: Glucose Monitoring,
Japan, Average Price ($), Forecast, 2008-2015 45
Table 22: Glucose
Monitoring, Japan, Distribution Share by Revenue ($mn), 2007-2008 46
Table
23: Glucose Monitoring, Japan, Company Share by Revenue ($ mn), 2006-2007
47
Table 24: Insulin Delivery, Japan, Revenue ($ mn) by Segment,
Historic, 2000-2008 48
Table 25: Insulin Delivery, Japan, Revenue ($
mn) by Segment, Forecast, 2008-2015 49
Table 26: Insulin Delivery,
Japan, Volume (Units) by Segment, Historic, 2000-2008 50
Table 27:
Insulin Delivery, Japan, Volume (Units) by Segment, Forecast, 2008-2015 51
Table 28: Insulin Delivery, Japan, Cross Segment Analysis, 2000-2015
52
Table 29: Insulin Delivery, Japan, Average Price ($), Historic,
2000-2008 53
Table 30: Insulin Delivery, Japan, Average Price ($),
Forecast, 2008-2015 54
Table 31: Insulin Delivery, Japan,
Distribution Share by Revenue ($mn), 2007-2008 55
Table 32: Insulin
Delivery, Japan, Company Share by Revenue ($ mn), 2006-2007 56
Table 33:
ARKRAY, Inc. Pipeline Products by Equipment Type 57
Table 34:
ARKRAY, Inc. Pipeline Products by Development Stage 57
Table 35:
ARKRAY, Inc. Pipeline Products by Clinical Trials 58
Table 36:
ARKRAY, Inc. Pipeline Products by News Summary 58
Table 37: F.
Hoffmann-La Roche Ltd Pipeline Products by Equipment Type 66
Table 38:
F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage 66
Table
39: F. Hoffmann-La Roche Ltd Pipeline Products by Therapy Area 66
Table 40: Bayer HealthCare AG Pipeline Products by Equipment Type 70
Table 41: Bayer HealthCare AG Pipeline Products by Development Stage
71
Table 42: Bayer HealthCare AG Pipeline Products by Therapy Area
71
Table 43: Bayer HealthCare AG Pipeline Products by News Summary
71
Table 44: Abbott Laboratories Pipeline Products by Equipment Type
76
Table 45: Abbott Laboratories Pipeline Products by Development
Stage 76
Table 46: Abbott Laboratories Pipeline Products by Therapy
Area 76
Table 47: Abbott Laboratories Pipeline Products by Clinical
Trials 77
Table 48: Abbott Laboratories Pipeline Products by News
Summary 77
Table 49: LifeScan, Inc. Pipeline Products by Equipment
Type 78
Table 50: LifeScan, Inc. Pipeline Products by Development
Stage 78
Table 51: LifeScan, Inc. Pipeline Products by Therapy Area
78
Table 52: LifeScan, Inc. Pipeline Products by Clinical Trials
79
Table 53: LifeScan, Inc. Pipeline Products by News Summary 79
Table 54: Medtronic, Inc. Pipeline Products by Equipment Type 83
Table 55: Medtronic, Inc. Pipeline Products By Development Stage 83
Table 56: Medtronic, Inc. Pipeline Products By Therapy Area 84
Table
57: Medtronic, Inc. Pipeline Products By Clinical Trials 84
Table 58:
Novo Nordisk A/S Pipeline Products by Equipment Type 85
Table 59:
Novo Nordisk A/S Pipeline Products By Development Stage 85
Table 60:
Novo Nordisk A/S Pipeline Products By Therapy Area 86
Table 61: Novo
Nordisk A/S Pipeline Products By Clinical Trials 86
Table 62: USD to
Local Currency, Average Exchange Rate 2008 93
1.2 List of Figures
Figure 1: Healthcare Expenditure in Japan, 2000 - 2005 15
Figure 2:
Government and Private Healthcare Expenditure in Japan, 2005 16
Figure 3:
Medical Device Classification in Japan, 2007 23
Figure 4: Approval Process
for Controlled Medical Devices in Japan, 2007 24
Figure 5: Approval
Process for Highly Controlled Medical Devices in Japan, 2007 25
Figure 6:
Health Insurance Reimbursement Process in Japan, 2007 29
Figure 7:
Distribution Structure for Medical Equipment in Japan, 2007 31
Figure 8:
Diabetes Care Devices, Japan, Overall Revenue ($ mn), Historic, 2000-2008
32
Figure 9: Diabetes Care Devices, Japan, Overall Revenue ($ mn),
Forecast, 2008-2015 33
Figure 10: Diabetes Care Devices, Japan,
Category Volume (Units) by Segment, Historic, 2000-2008 34
Figure 11:
Diabetes Care Devices, Japan, Category Volume (Units) by Segment, Forecast,
2008-2015 35
Figure 12: Diabetes Care Devices, Japan, Cross-Category
Analysis, 2000-2015 36
Figure 13: Diabetes Care Devices, Japan,
Company Share (%), 2007 38
Figure 14: Glucose Monitoring, Japan,
Revenue ($ mn) by Segment, Historic, 2000-2008 40
Figure 15: Glucose
Monitoring, Japan, Revenue ($ mn) by Segment, Forecast, 2008-2015 41
Figure 16: Glucose Monitoring, Japan, Volume (Units) by Segment,
Historic, 2000-2008 42
Figure 17: Glucose Monitoring, Japan, Volume
(Units) by Segment, Forecast, 2008-2015 43
Figure 18: Glucose
Monitoring, Japan, Cross Segment Analysis, 2000-2015 44
Figure 19:
Glucose Monitoring, Japan, Company Share (%), 2007 47
Figure 20:
Insulin Delivery, Japan, Revenue ($ mn) by Segment, Historic, 2000-2008 48
Figure 21: Insulin Delivery, Japan, Revenue ($ mn) by Segment, Forecast,
2008-2015 49
Figure 22: Insulin Delivery, Japan, Cross Segment
Analysis, 2000-2015 52
Figure 23: Insulin Delivery, Japan, Company
Share (%), 2007 56
Figure 24: Terumo Corporation Value Chain Analysis
59
Figure 25: F. Hoffmann-La Roche Ltd Value Chain Analysis 63
Figure 26: Bayer HealthCare AG Value Chain Analysis 68
Figure 27:
Abbott Laboratories Value Chain Analysis 73
Figure 28: Medtronic,
Inc. Value Chain Analysis 81
Figure 29: GlobalData Methodology 89
|
Related Report
|
View Cart
